| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 10.25B | 10.06B | 10.51B | 10.30B | 9.10B |
| Gross Profit | 3.72B | 3.65B | 3.37B | 3.06B | 2.83B |
| EBITDA | 2.75B | 2.61B | 2.85B | 2.27B | 1.79B |
| Net Income | 661.98M | 600.30M | 501.20M | 391.60M | 244.50M |
Balance Sheet | |||||
| Total Assets | 30.64B | 28.68B | 27.36B | 25.49B | 26.57B |
| Cash, Cash Equivalents and Short-Term Investments | 4.86B | 3.92B | 3.37B | 2.68B | 3.41B |
| Total Debt | 13.01B | 12.62B | 11.71B | 11.22B | 11.13B |
| Total Liabilities | 17.52B | 16.75B | 15.79B | 15.13B | 15.95B |
| Stockholders Equity | 4.39B | 3.93B | 3.69B | 3.30B | 3.30B |
Cash Flow | |||||
| Free Cash Flow | 1.57B | 388.10M | 526.60M | 1.12B | 872.50M |
| Operating Cash Flow | 2.12B | 1.75B | 1.73B | 1.42B | 1.25B |
| Investing Cash Flow | -1.06B | -1.63B | -1.48B | -2.01B | -730.50M |
| Financing Cash Flow | -171.25M | 466.90M | 88.00M | 75.30M | 305.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$123.17B | 4.56 | 14.19% | 6.66% | 7.95% | -2.88% | |
67 Neutral | HK$52.52B | 8.37 | 23.50% | 3.26% | 2.03% | 1.43% | |
66 Neutral | HK$24.35B | 3.01 | 15.20% | 4.46% | 1.65% | 9.66% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | HK$68.15B | ― | 24.09% | 5.46% | -1.95% | 20.50% | |
59 Neutral | HK$66.93B | -26.78 | 3.79% | 3.62% | -7.24% | 1390.75% | |
45 Neutral | HK$6.32B | -1.54 | -7.94% | ― | 13.83% | -240.97% |